Cellebrite (CLBTW) Form 144: RSU Sale Planned and Recent Insider Sale Disclosed

Rhea-AI Filing Summary

Cellebrite DI Ltd. (CLBTW) Form 144 summary: An individual filed a notice to sell 7,867 common shares through Morgan Stanley Smith Barney LLC on 08/19/2025, with an aggregate market value of $127,130.72. The filing reports the shares were acquired as Restricted Stock Units from the issuer on 08/15/2025 and paid on 08/15/2025. The filing also discloses a prior sale by Marcus H Jewell of 15,995 common shares on 08/18/2025 for $249,522.00. The notice states the signer represents no undisclosed material adverse information.

Positive

• Transaction disclosed with broker details (Morgan Stanley Smith Barney LLC) providing transparency on execution channel
• Acquisition details included (Restricted Stock Units dated 08/15/2025) clarifying source of the shares
• Prior sale disclosed (15,995 shares sold on 08/18/2025 for $249,522.00), improving transparency about recent insider activity

Negative

• Insider liquidity events include a recent sale (15,995 shares) and an intended sale (7,867 shares) within consecutive days, which investors may view as insider selling
• Filing lacks issuer-specific context within the form (no operational or financial metrics provided) to explain reasons for sales

Insights

Securities Analyst

TL;DR: Insider sale notice filed for 7,867 common shares following a recent sale of 15,995 shares.

The Form 144 shows a planned brokered sale of 7,867 common shares via Morgan Stanley on 08/19/2025, acquired as RSUs on 08/15/2025. A separate sale of 15,995 shares occurred on 08/18/2025 for $249,522. The disclosure is procedural under Rule 144 to permit resale of restricted shares and provides explicit quantities, dates, and proceeds. For investors, the filing documents insider liquidity events but does not include operational or financial performance information.

Compliance / Risk Analyst

TL;DR: Documentation appears compliant with Rule 144 requirements; includes seller representation about nondisclosure of material adverse information.

The form lists acquisition method (Restricted Stock Units), acquisition and payment dates, broker details, and prior recent sales, fulfilling required disclosure fields. The signer affirms no undisclosed material adverse information and the form warns against intentional misstatements. The filing contains no additional risk disclosures or company-specific operational data.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7867	127130.72	244469106	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Restricted Stock Units	Issuer			7867	08/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARCUS H JEWELL 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	08/18/2025	15995	249522.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CLBTW Form 144 disclose about the planned sale?

The filing discloses an intended sale of 7,867 common shares through Morgan Stanley Smith Barney LLC on 08/19/2025 with aggregate market value of $127,130.72.

How were the shares being sold acquired according to the filing?

The shares were acquired as Restricted Stock Units from the issuer on 08/15/2025, with payment dated 08/15/2025.

Did the filer report any recent sales of the issuer's securities?

Yes. The filing shows Marcus H Jewell sold 15,995 common shares on 08/18/2025 for gross proceeds of $249,522.00.

Who is the broker handling the proposed sale?

The proposed sale is to be executed by Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York, NY.

Does the Form 144 include any statement about undisclosed material information?

Yes. The person for whose account the securities are to be sold represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.